Psilocybin may improve a difficult-to-treat symptom of depression, study finds
Reported byCU Anschutz ↗·Sourced by Goodlede
A clinical trial at the University of Colorado Anschutz found significant improvement in anhedonia—the loss of ability to experience pleasure—eight weeks after psilocybin treatment in people with treatment-resistant depression.
This is an early clinical trial. More research is needed before the findings can be translated into routine treatment.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at CU Anschutz
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede